| Name | Hetramine |
|---|---|
| Synonyms |
N-Benzyl-N',N'-dimethyl-N-pyrimidin-2-yl-aethylendiamin
2971RP 2-[Benzyl(2-dimethylaminoethyl)amino]pyrimidine N-(2-Dimethylaminoethyl)-N-benzylpyrimidin-2-amine N-benzyl-N',N'-dimethyl-N-pyrimidin-2-yl-ethylenediamine benzyl-(2-dimethylaminoethyl)-pyrimidin-2-yl-amine RP 2971 N',N'-dimethyl-N-(phenylmethyl)-N-pyrimidin-2-yl-ethane-1,2-diamine |
| Density | 1.108g/cm3 |
|---|---|
| Boiling Point | 404.6ºC at 760mmHg |
| Molecular Formula | C15H20N4 |
| Molecular Weight | 256.34600 |
| Flash Point | 198.5ºC |
| Exact Mass | 256.16900 |
| PSA | 32.26000 |
| LogP | 2.04480 |
| Index of Refraction | 1.597 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2933599090 |
|---|
|
~%
531-08-8 |
| Literature: Sunagawa et al. Yakugaku Zasshi, 1952 , vol. 72, p. 1570,1572 Chem.Abstr., 1953 , p. 9285 Full Text Show Details Nepera Chem.Co. Patent: DE823598 , 1951 ; DRP/DRBP Org.Chem. Full Text Show Details Pyridium Corp. Patent: US2465865 , 1946 ; Full Text Show Details Soc.Usines Chim.Rhone-Poulenc Patent: DE880749 , 1951 ; DRP/DRBP Org.Chem. Full Text Show Details Matsukawa et al. Yakugaku Zasshi, 1951 , vol. 71, p. 1316 Chem.Abstr., 1952 , p. 8123 Full Text Show Details Saijo Yakugaku Zasshi, 1952 , vol. 72, p. 1447,1450 Chem.Abstr., 1953 , p. 8080 |
|
~%
531-08-8 |
| Literature: Mossini; Maggiali; Morini; Impicciatore; Molina Farmaco, Edizione Scientifica, 1984 , vol. 39, # 3 p. 189 - 199 |
|
~%
531-08-8 |
| Literature: Nepera Chem.Co. Patent: DE823598 , 1951 ; DRP/DRBP Org.Chem. |
|
~%
531-08-8 |
| Literature: Saijo Yakugaku Zasshi, 1952 , vol. 72, p. 1447,1450 Chem.Abstr., 1953 , p. 8080 |
|
~%
531-08-8 |
| Literature: Mossini; Maggiali; Morini; Impicciatore; Molina Farmaco, Edizione Scientifica, 1984 , vol. 39, # 3 p. 189 - 199 |
|
~%
531-08-8 |
| Literature: Matsukawa et al. Yakugaku Zasshi, 1951 , vol. 71, p. 1316 Chem.Abstr., 1952 , p. 8123 |
| Precursor 9 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |